All News

Researchers may be able to use imaging mass cytometry to capture and classify the tumor-immune evasion cell networks in clear cell renal cell carcinoma.

The PARP inhibitor olaparib demonstrated antitumor activity in patients with BAP1-mutated renal cell carcinoma.

“Although the future of AI within science is uncertain, disclosure of the use of AI is an excellent first step to balance academic integrity with disruptive innovation,” the authors write.

From urologic oncology and pediatric oncology to single port robotic surgery, the Department of Urology team is celebrating several achievements.

Analysis shows MRI is comparable to post-surgery pathologic staging for assessing risk of biochemical recurrence.

"The beauty is, now we can deliver a cisplatin-based chemotherapeutic orally, which is usually never done. And by targeting the prostate, we can reduce kidney and liver toxicity and the risk of peripheral neuropathy," says Shanta Dhar, PhD.

The prospective cohort study seeks to enroll 200 patients from the South Florida region and 1800 patients from international sites.

Urologists and other medical professionals can begin using the code on January 1, 2024 to facilitate the reimbursement of Li-ESWT involving the corpus cavernosum.

“Regardless of the size of the practice, medical scribes are a valuable resource for health care providers, helping to streamline workflow and coordinate patient care,” writes Brian Hudson.

“Implementing Jelmyto earlier in real-world scenarios for LG-UTUC may offer appropriate low-risk patients the choice of minimal ablation or biopsy alone for renal preservation," says Hristos Z. Kaimakliotis, MD.

Smaller incision may lead to reduced postoperative pain for some patients.

Data showed a decrease in patient symptoms following Aquablation procedures, with an average IPSS of 22.6 at baseline compared with 6.8 at 5-year follow-up.

Patients receiving nivolumab plus cisplatin-based chemotherapy lived longer than patients treated with standard chemotherapy alone.

The minimally invasive surgical therapy is approved for the treatment of lower urinary tract symptoms secondary to BPH.

"One of the things that made a difference, at least in my practice, was one of the newer pulse modulated holmium lasers," says Smita De, MD, PhD.

“Our findings show that race-modified equations account for some but not all of the disparity in partial nephrectomy use. We need to keep searching for answers to ensure people of all races receive appropriate care," said Christopher Weight, MD.

"Our most significant finding may be that patients experience financial toxicity despite their ability to remain compliant with treatment," says Daniel D. Joyce, MD.

When you add automation, your medical coding not only improves your margins but also plays a key role in improving patient care.

“This study truly changes the paradigm of infections and suggests we need to work smarter, not harder, to prevent infections,” said urologist Scott Lundy, MD, PhD.

"The fact that we are able to swab and look at these proteins means that we might be able to identify women at risk early on,” says Maria Florian-Rodriguez, MD.

"An attorney who just reads off a script spewing random facts at the jury will likely cause the jurors to check out," writes Kenton H. Steele, Esq.

A group of patients were shown to have an average of 6.3 cystitis episodes per year before administration of Lactobacillus, compared with 2.4 episodes after administration.

The study will assess the ability of Cu-64 SAR-bisPSMA to detect prostate cancer within the pelvic lymph nodes.

"Another thing is to customize your EHR with favorite orders and grouped orders, and these things can be standardized across a practice," says Sarah Hecht, MD.

Awardees are being recognized for creative approaches to accelerating progress in bladder cancer research.

“To our knowledge, these results are the first to suggest an association between second-generation [antiandrogens] and cognitive and functional toxic effects based on data from prospective [randomized controlled trials],” the investigators wrote.

UroMonitor was developed in response to conventional urodynamics, which have several limitations.

"The high reproducibility of reader results across all regions is clinically valuable, with the potential to influence patient management prior to surgery for patients with newly diagnosed disease," says Phillip H. Kuo, MD, PhD.